Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Researchers at the Crick and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort.
7 Apr 2021
United Kingdom
Crick news

Featured

Academia to Industry

To view this News Article please log in or create a profile

Similar stories

Crick news

Alumni spotlight! Request for more profiles, share your story!

Have you read about Katrien and Abi's work? They recently shared details about their work and background as part of the new "Alumni spotlight" section of CrickConnect. More...
Karen Vousden wins AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research

More...

Pictured: Magdalena Armas Reyes
Three Crick PhD students present at the STEM for BRITAIN finals

We are delighted that the shortlist for this year's STEM for BRITAIN competition included three Crick PhD students: Oliv… More...
Scientists decide makeup of this year's flu vaccine

More...
2025 summer student training programme is now open for applications

Do you know a second year undergraduate looking for hands-on research training? More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


Check out

Community
Mentoring
Careers
News
Groups
Events

Legal

Terms
Privacy
Cookies
About
Contact

Alumni Management Software powered by
ToucanTech